To better understand how BRCA2-mutant prostate organoids can tolerate deletion of these pre-RC complex genes, we examined the dependency profiles of CDT1, CDC6, and DBF4 in the cancer cell line dependency map (DepMap; https://depmap.org/portal/). This evidence concerns the gene CDC6 and cancer.